Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
7.72T | 5.88T | 6.06T | 4.70T | 4.63T | 5.02T | Gross Profit |
8.95T | 10.70T | 6.06T | 4.70T | 4.63T | 5.02T | EBIT |
1.79T | 0.00 | 3.86T | 1.96T | 962.09B | 749.05B | EBITDA |
7.04T | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Net Income Common Stockholders |
1.49T | 1.49T | 1.12T | 1.13T | 777.02B | 528.15B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
12.10T | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> | Total Assets |
10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> | Total Debt |
0.00 | 25.75T | 47.28T | 19.11T | 18.09T | 44.91T | Net Debt |
-12.10T | -84.13T | -66.35T | -91.65T | -84.89T | -33.42T | Total Liabilities |
10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> | Stockholders Equity |
10.55T | 19.59T | 17.23T | 17.02T | 16.80T | 15.99T |
Cash Flow | Free Cash Flow | ||||
0.00 | -10.31T | 13.03T | 9.25T | 34.51T | 7.61T | Operating Cash Flow |
0.00 | -9.84T | 13.43T | 9.64T | 34.90T | 8.06T | Investing Cash Flow |
0.00 | -1.27T | -10.68T | -2.20T | -10.14T | -3.37T | Financing Cash Flow |
0.00 | 8.31B | -977.14B | -875.97B | -436.07B | -251.66B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | $116.86B | 8.34 | 13.25% | 2.17% | 0.27% | 19.44% | |
80 Outperform | $206.83B | 10.87 | 10.30% | 5.57% | -1.91% | -6.79% | |
78 Outperform | $247.90B | 13.69 | 11.05% | 2.03% | 3.51% | 16.51% | |
74 Outperform | $92.53B | 12.09 | 7.92% | 2.30% | 8.69% | 50.61% | |
65 Neutral | $151.75B | 12.90 | 9.18% | 1.74% | 13.21% | -12.06% | |
64 Neutral | $141.42B | 11.96 | 6.30% | 2.92% | 2.97% | 87.82% | |
64 Neutral | $12.82B | 9.83 | 7.68% | 17000.34% | 12.38% | -5.56% |